Physician profile
Bryan Patrick Williams
NPI 1851883151
$19,476.76
in general payments reported to CMS, 2019-2025
21 companies · $9,798 in 2025
The $9,798 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,069 · 2020: $194 · 2021: $316 · 2022: $755 · 2023: $699 · 2024: $4,645 · 2025: $9,798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,090 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,713 · Food and Beverage: $2,860 · Gift: $480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,090.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,712.50 |
| Food and Beverage | $2,859.80 |
| Gift | $480.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $7,972.18 | 2019-2025 | Dailies Total1, Precision 1, Total30 |
| Bausch & Lomb Americas INC. | $6,017.67 | 2024-2025 | Zenlens, Miebo, Xiidra |
| Valley Contax, INC. | $1,430.01 | 2019 | |
| Biotissue Holdings INC. | $621.60 | 2019-2025 | |
| Johnson & Johnson Vision Care, INC. | $509.29 | 2019-2023 | Acuvue, Axert |
| Visionary Optics LLC | $480.00 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $408.25 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $344.87 | 2023-2025 | Cequa |
| Glaukos Corporation | $330.06 | 2022-2025 | Photrexa Viscous and Photrexa |
| Carl Zeiss Meditec USA, INC. | $222.29 | 2022-2024 | Cirrus Hd-Oct |
| Lumenis Be INC | $168.50 | 2023 | Optilight |
| Novartis Pharmaceuticals Corporation | $146.37 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $135.04 | 2023 | Tecnis Iol |
| Sight Sciences, INC. | $134.78 | 2025 | Omni Surgical System |
| Dompe US, INC. | $134.54 | 2022-2025 | Oxervate |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $107.14 | 2025 | Vevye |
| Astellas Pharma US INC | $103.02 | 2023 | |
| Allergan, INC. | $93.84 | 2022 | |
| Derma Sciences, INC. | $57.71 | 2019 | |
| Shire North American Group INC | $32.06 | 2019 | |
| Coopervision INC. | $27.54 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.